Comparative Pharmacology
Head-to-head clinical analysis: MIRALAX versus NULYTELY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MIRALAX versus NULYTELY.
MIRALAX vs NULYTELY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Polyethylene glycol 3350 (PEG 3350) is an osmotic laxative that works by retaining water in the stool through hydrogen bonding, increasing fecal water content and promoting bowel movements.
Polyethylene glycol (PEG) 3350 is an osmotic agent that induces diarrhea by drawing water into the gastrointestinal tract, thereby cleansing the bowel. Sodium sulfate and electrolytes (sodium, potassium, bicarbonate) are added to prevent fluid and electrolyte shifts.
17 g (1 heaping tablespoon) dissolved in 4–8 oz of water, juice, soda, coffee, or tea, administered orally once daily. Maximum duration of use: 7 days.
4 liters orally of the reconstituted solution as a single dose for colonoscopy preparation, typically administered in divided doses (e.g., 240 mL every 10 minutes) until rectal effluent is clear. Alternatively, a split-dose regimen: half the solution evening before, half on the day of procedure.
None Documented
None Documented
Not applicable; polyethylene glycol 3350 is minimally absorbed and systemic half-life is not clinically relevant.
Not applicable; NULYTELY is not systemically absorbed in significant amounts, so a terminal elimination half-life is not defined. The drug acts locally in the gastrointestinal tract.
Primarily excreted unchanged in feces (>90% of oral dose); negligible renal elimination (<0.1% recovered in urine).
NULYTELY (polyethylene glycol 3350) is minimally absorbed systemically (<0.06%). The primary route of elimination is fecal excretion of the intact polymer. Renal excretion is negligible (<0.02%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative